172 related articles for article (PubMed ID: 38173297)
1. Longitudinal Associations of Magnetic Susceptibility with Clinical Severity in Parkinson's Disease.
Thomas GEC; Hannaway N; Zarkali A; Shmueli K; Weil RS
Mov Disord; 2024 Mar; 39(3):546-559. PubMed ID: 38173297
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Susceptibility Mapping in Parkinson's Disease.
Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
[TBL] [Abstract][Full Text] [Related]
3. Extra-basal ganglia iron content and non-motor symptoms in drug-naïve, early Parkinson's disease.
Kim M; Yoo S; Kim D; Cho JW; Kim JS; Ahn JH; Mun JK; Choi I; Lee SK; Youn J
Neurol Sci; 2021 Dec; 42(12):5297-5304. PubMed ID: 33860863
[TBL] [Abstract][Full Text] [Related]
4. Brain iron deposition is linked with cognitive severity in Parkinson's disease.
Thomas GEC; Leyland LA; Schrag AE; Lees AJ; Acosta-Cabronero J; Weil RS
J Neurol Neurosurg Psychiatry; 2020 Apr; 91(4):418-425. PubMed ID: 32079673
[TBL] [Abstract][Full Text] [Related]
5. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
6. Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia.
Li DTH; Hui ES; Chan Q; Yao N; Chua SE; McAlonan GM; Pang SYY; Ho SL; Mak HKF
Neuroimage Clin; 2018; 20():365-373. PubMed ID: 30128274
[TBL] [Abstract][Full Text] [Related]
7. The applied value in brain gray matter nuclei of patients with early-stage Parkinson's disease : a study based on multiple magnetic resonance imaging techniques.
Meng H; Zhang D; Sun Q
Head Face Med; 2023 Jun; 19(1):25. PubMed ID: 37386479
[TBL] [Abstract][Full Text] [Related]
8. Magnetic Susceptibility Associates With Dopaminergic Deficits and Cognition in Parkinson's Disease.
Uchida Y; Kan H; Sakurai K; Inui S; Kobayashi S; Akagawa Y; Shibuya K; Ueki Y; Matsukawa N
Mov Disord; 2020 Aug; 35(8):1396-1405. PubMed ID: 32369660
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of QSM over R2* in assessment of parkinson's disease - A systematic review.
Saikiran P;
Neurol India; 2020; 68(2):278-281. PubMed ID: 32415005
[TBL] [Abstract][Full Text] [Related]
10. MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson's disease: Observational and genetic analysis in the UK Biobank cohort.
Casanova F; Tian Q; Williamson DS; Qian Y; Zweibaum D; Ding J; Atkins JL; Melzer D; Ferrucci L; Pilling LC
Neurobiol Dis; 2024 Jul; 197():106539. PubMed ID: 38789058
[TBL] [Abstract][Full Text] [Related]
11. Non-Motor Symptom Burdens Are Not Associated with Iron Accumulation in Early Parkinson's Disease: a Quantitative Susceptibility Mapping Study.
Shin C; Lee S; Lee JY; Rhim JH; Park SW
J Korean Med Sci; 2018 Mar; 33(13):e96. PubMed ID: 29573246
[TBL] [Abstract][Full Text] [Related]
12. Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson's Disease: A 7 Tesla Imaging Study.
Poston KL; Ua Cruadhlaoich MAI; Santoso LF; Bernstein JD; Liu T; Wang Y; Rutt B; Kerchner GA; Zeineh MM
J Parkinsons Dis; 2020; 10(2):591-604. PubMed ID: 32250317
[TBL] [Abstract][Full Text] [Related]
13. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.
Du G; Lewis MM; Sica C; He L; Connor JR; Kong L; Mailman RB; Huang X
Mov Disord; 2018 Sep; 33(9):1423-1431. PubMed ID: 29756399
[TBL] [Abstract][Full Text] [Related]
14. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
[TBL] [Abstract][Full Text] [Related]
15. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
[TBL] [Abstract][Full Text] [Related]
16. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L
Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654
[TBL] [Abstract][Full Text] [Related]
17. Increased iron in the substantia nigra pars compacta identifies patients with early Parkinson'sdisease: A 3T and 7T MRI study.
Alushaj E; Handfield-Jones N; Kuurstra A; Morava A; Menon RS; Owen AM; Sharma M; Khan AR; MacDonald PA
Neuroimage Clin; 2024; 41():103577. PubMed ID: 38377722
[TBL] [Abstract][Full Text] [Related]
18. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.
Guan X; Xuan M; Gu Q; Huang P; Liu C; Wang N; Xu X; Luo W; Zhang M
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26853890
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Susceptibility Mapping and Free Water Imaging of Substantia Nigra in Parkinson's Disease.
Zhang D; Yao J; Sun J; Tong Q; Zhu S; Wang J; Chen L; Ma J; He H; Wu T
J Parkinsons Dis; 2022; 12(8):2469-2478. PubMed ID: 36404557
[TBL] [Abstract][Full Text] [Related]
20. Distribution pattern of iron deposition in the basal ganglia of different motor subtypes of Parkinson's disease.
Zhang X; Li L; Qi L; Fu Y; Sun D; Chen S; Xu W; Liu C; Zhou X; He G
Neurosci Lett; 2023 Jun; 807():137249. PubMed ID: 37061026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
